As of April 19, 2025, Genenta Science (GNTA) has a market cap of $70.965 million USD. According to our data, Genenta Science is ranked No.7831 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $70.96 M |
-10.80%
|
Dec 31, 2024 | $79.56 M |
-12.12%
|
Dec 29, 2023 | $90.54 M |
-10.00%
|
Dec 30, 2022 | $0.10 B |
-49.83%
|
Dec 31, 2021 | $0.20 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.20 B |
49.857 M
|
![]() France
|
![]() Precision BioSciences
DTIL
|
$52.96 M |
-0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.70 B |
-0.000 M
|
![]() Netherlands
|
Market Cap | = | GNTA Stock Price | * | GNTA Shares Outstanding |
= | $3.88 | * | 18.29 M | |
= | $70.96 M |